HYDROCHLOROTHIAZIDE (HCTZ) USE IS ASSOCIATED WITH INCREASED RISK OF BASAL CELL AND SQUAMOUS CELL CARCINOMA

RSB Dermatology

A recent study published in the Journal of the American Academy of Dermatology has shown that taking hydrochlorothiazide (HCTZ) is associated with an increased risk of basal cell carcinoma and an even higher risk of squamous cell carcinoma. The risk was dose dependent (the higher the cumulative dose, the higher the risk). An increased risk…

Read More

EYELID DERMATITIS IN WOMEN: HOME REMEDIES

RSB Dermatology

Eyelid dermatitis in women is fairly common.  In many cases, the initial cause is irritation incurred during the removal of make-up. Mechanical friction, often with a wash cloth or other cleaning product, removes some critical components of the outer layer of the skin that protects the skin. After this occurs, things that normally would not…

Read More

INFECTIONS AFTER A PEDICURE

RSB Dermatology

Patients often ask about the risk of getting infections after a Pedicure. In most cases, they are asking about getting a toenail fungal infection, which is rare in this circumstance. Bacterial infections have occurred after getting a Pedicure, although is uncommon. Those who are immuno-compromised or have diabetes and/or poor circulation are more at risk…

Read More

I HAVE A SKIN PROBLEM: WHO SHOULD I SEE?

RSB Dermatology

Without question, it is ALWAYS best to see a well-trained, board-certified Dermatologist if one has any skin problems (rashes or growths).  Although many PCPs and Urgent care centers can handle COMMON problems (i.e. Shingles, poison ivy and minor burns), what happens when both you and the doctor does not know what the diagnosis is? In many of these cases, patients…

Read More

NEW DRUGS FOR PSORIASIS LOOKING GREAT!

RSB Dermatology

TYK2 inhibitor is being developed by Bristol-Myers Squibb and the early Phase II trial results have been great. Why? Here is the scientific talk: the TYK2 inhibitor has been shown to be 100 times more selective in inhibiting IL-23 , IL-12, and interferon-alpha than JAK 1/3 inhibitors and 3,000 times more selective than JAK 2 inhibitors. What do you…

Read More

“BETTER THAN BOTOX?”

RSB Dermatology

Revance Therapeutics Inc. said that an experimental drug RT002 [injectable daxibotulinumtoxinA] can smooth wrinkles for longer than Allergan’s Botox, according to the results of late-stage studies. We will have to wait for the published data to see, but at least early reports look promising.

Read More